India’s Precision Medicine: A Vision Hindered by Biobank Regulations
Precision medicine, a transformative approach to healthcare, is redefining the landscape of disease diagnosis and treatment. From groundbreaking personalised healthcare solutions to innovations like mRNA vaccines and gene-editing technologies, the field promises a new era in medical science. Yet, as India stands on the cusp of this revolution, a significant hurdle looms: the lack of robust biobank regulations.
Biobanks, essential repositories of biological samples, are critical to the success of precision medicine. These collections of blood, DNA, and tissue samples, coupled with genetic data, form the backbone of research aimed at developing targeted therapies for diseases like cancer and diabetes. However, as highlighted in a recent analysis by The Hindu, India’s inconsistent biobank regulations threaten public trust and impede progress.
The Promise of Precision Medicine
In recent years, precision medicine has witnessed remarkable achievements. Through gene therapy, researchers have restored vision in individuals with genetic mutations, while in the U.K., scientists have reversed diabetes using reengineered stem cells. The rapid development of COVID-19 vaccines using the mRNA platform, which earned a Nobel Prize, further underscores the potential of precision medicine.
India’s Growing Market
The Indian precision medicine market is burgeoning, with projections estimating a value exceeding $5 billion by 2030. Initiatives like the BioE3 policy and the approval of NexCAR19, a domestically developed CAR-T cell therapy, mark significant strides. However, the true potential of these advancements lies in aligning biobank regulations with international standards.
The Biobank Conundrum
While countries like the U.K., U.S., and Japan have comprehensive biobank regulations ensuring data protection and privacy, India’s framework remains fragmented. The absence of a single authority to regulate biobanks and the lack of penalties for misconduct create risks of ethical violations and undermine public confidence. As the ICMR guidelines illustrate, participants often consent to provide samples without clarity on data usage, raising concerns about privacy and potential discrimination.
A Path Forward
To harness the full potential of precision medicine, India must establish stringent biobank regulations. Aligning with global standards will not only bolster public trust but also position India as a leader in next-generation therapeutics. As part of international groups like the Quad and BRICS, India has the opportunity to expand its pharmaceutical leadership and enhance its soft diplomatic efforts.
Manjeera Gowravaram, a PhD in RNA biochemistry, provides insightful analysis on the intersection of science and policy.
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
Cybercrime in 2025 has evolved into a full‑scale service economy, with malware now available through subscription platforms that operate like mainstream tech businesses. Bitsight’s latest analysis reveals explosive growth in Malware‑as‑a‑Service tools, rising attacks across industries like healthcare, finance, tech, and real estate, and a surge in cross‑platform malware and supply‑chain exploits. For professionals in any licensed field, the message is clear: today’s digital landscape demands heightened vigilance, stronger identity security, and proactive defense against an increasingly organized underground threat environment.
A new proptech startup in the UAE, Gllit is redefining how property deals happen by removing agents, eliminating commissions, and integrating AI tools that let users create professional listings in seconds. With a fast, transparent, and direct-to-owner model, Gllit offers a glimpse into the future of global real estate — and a powerful case study for U.S. professionals preparing for tech-driven changes in the industry.
The 2026 housing market is shaping up to be a year of stability with a few surprises. Mortgage rates are expected to hold steady, home price growth is slowing, and yet ownership costs continue to rise due to soaring taxes and insurance. Meanwhile, renting is becoming more attractive as affordability improves and built‑to‑rent communities expand. This breakdown highlights the biggest trends ahead — and what they mean for buyers, sellers, and real estate professionals, especially in Florida.
Florida homeowners are facing some of the highest insurance premiums in the nation, with average costs now topping $5,800 per year—about $3,000 above the U.S. average. Many residents report their rates have doubled or even tripled, while more than 40 percent of claims are closed with no payment. As frustration grows, state lawmakers and consumer advocates are pushing for transparency, rate caps, and incentives to help storm‑proof homes. The outcome of these reform efforts could reshape Florida’s real estate market, insurance landscape, and affordability for years to come.
A new global study from Risk.net and SAS reveals that many insurance companies are still making key decisions in isolated silos, despite industry-wide pushes toward data-driven strategies. While most leaders claim to have a clear vision, 38 percent admit they lack a real-time view of risks, revenue and costs. With poor data quality, limited collaboration and outdated processes holding teams back, experts say the industry is poised for a major transformation through AI, analytics and unified strategy—offering lessons for professionals across insurance, real estate, finance and other regulated fields.
Atlanta’s housing market is shifting into a more balanced and predictable phase. Prices have leveled off, inventory has finally caught up, and mortgage rates are easing enough to bring buyers back into the game. With steady demand, growing listings, and only mild price corrections forecasted into 2026, Atlanta remains one of the Southeast’s strongest real estate markets for buyers, sellers, and investors alike.
Biobanks, essential repositories of biological samples, are critical to the success of precision medicine. These collections of blood, DNA, and tissue samples, coupled with genetic data, form the backbone of research aimed at developing targeted therapies for diseases like cancer and diabetes. However, as highlighted in a recent 
While countries like the U.K., U.S., and Japan have comprehensive biobank regulations ensuring data protection and privacy, India’s framework remains fragmented. The absence of a single authority to regulate biobanks and the lack of penalties for misconduct create risks of ethical violations and undermine public confidence. As the 
